Viewing StudyNCT00154102



Ignite Creation Date: 2024-05-05 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00154102
Status: COMPLETED
Last Update Posted: 2017-01-30
First Post: 2005-09-08

Brief Title: Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer CRYSTAL
Sponsor: Merck KGaA Darmstadt Germany
Organization: Merck KGaA Darmstadt Germany

Conditions & Keywords Data

Conditions:
Name
Epidermal Growth Factor Receptor EGFR Expressing Metastatic Colorectal Cancer
Keywords:
Name View
first-line treatment View
Metastatic colorectal cancer View
EGFR View
Irinotecan View
cetuximab View